Sotera Health Company Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	1,150	1,100	1,049	1,004	931.48	818.16
Revenue Growth (YoY)	2.67%	4.88%	4.54%	7.75%	13.85%	5.12%
Cost of Revenue	506.4	498.15	472.13	446.68	412.81	374.59
Gross Profit	643.98	602.3	577.16	557	518.67	443.57
Selling, General & Admin	196.28	204.75	186.37	166.18	149.36	136.6
Amortization of Goodwill & Intangibles	43.1	62.04	63.8	62.94	63.78	59.03
Operating Expenses	239.37	266.79	250.16	229.12	213.14	195.63
Operating Income	404.61	335.51	326.99	327.89	305.53	247.94
Interest Expense	-161.63	-164.69	-142.88	-80.14	-74.19	-215.26
Currency Exchange Gain (Loss)	-1.82	-0.2	-0.16	-0.15	-1.35	5.23
Other Non Operating Income (Expenses)	-5.21	0.12	2.38	-0.46	3.56	4.16
EBT Excluding Unusual Items	235.94	170.74	186.34	247.14	233.55	42.07
Gain (Loss) on Sale of Investments	-	-	-	-9.61	-	-
Legal Settlements	-112.8	-32.69	-80.31	-480.64	-45.66	-36.67
Other Unusual Items	-1.18	-24.17	-	-	-15.58	-44.26
Pretax Income	121.97	113.87	106.03	-243.11	175.72	-38.86
Income Tax Expense	66.55	69.48	54.65	-9.54	58.6	-1.37
Earnings From Continuing Operations	55.43	44.4	51.38	-233.57	117.12	-37.49
Minority Interest in Earnings	-	-	-	-	-0.24	-1.13
Net Income	55.43	44.4	51.38	-233.57	116.88	-38.62
Preferred Dividends & Other Adjustments	0.01	0.06	0.29	-	1.52	-
Net Income to Common	55.42	44.34	51.09	-233.57	115.36	-38.62
Net Income Growth	-21.67%	-13.58%	-	-	-	-
Shares Outstanding (Basic)	284	283	281	280	279	238
Shares Outstanding (Diluted)	286	285	283	280	279	238
Shares Change (YoY)	0.56%	0.60%	1.12%	0.26%	17.54%	2.28%
EPS (Basic)	0.20	0.16	0.18	-0.83	0.41	-0.16
EPS (Diluted)	0.20	0.16	0.18	-0.83	0.41	-0.16
EPS Growth	-21.74%	-12.89%	-	-	-	-
Free Cash Flow	86.62	45.09	-362.71	95.58	179.38	67.08
Free Cash Flow Per Share	0.30	0.16	-1.28	0.34	0.64	0.28
Gross Margin	55.98%	54.73%	55.01%	55.50%	55.68%	54.22%
Operating Margin	35.17%	30.49%	31.16%	32.67%	32.80%	30.30%
Profit Margin	4.82%	4.03%	4.87%	-23.27%	12.38%	-4.72%
Free Cash Flow Margin	7.53%	4.10%	-34.57%	9.52%	19.26%	8.20%
EBITDA	551.56	501.78	487.33	475.63	458.68	393.5
EBITDA Margin	47.95%	45.60%	46.44%	47.39%	49.24%	48.10%
D&A For EBITDA	146.95	166.28	160.34	147.75	153.15	145.56
EBIT	404.61	335.51	326.99	327.89	305.53	247.94
EBIT Margin	35.17%	30.49%	31.16%	32.67%	32.80%	30.30%
Effective Tax Rate	54.56%	61.01%	51.54%	-	33.35%	-
Revenue as Reported	1,150	1,100	1,049	1,004	931.48	818.16

Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q